Bone Morphogenetic Protein in the Cervical Spine: Efficacy and Associated Risks
23 Bone Morphogenetic Protein in the Cervical Spine: Efficacy and Associated Risks CYRUS E. TAGHAVI AND JEFFREY C. WANG In July 2002, the U.S. Food and Drug Administration (FDA) approved…